Skip to main content
. 2017 Nov 29;7(12):635. doi: 10.1038/s41408-017-0011-1

Fig. 1.

Fig. 1

Overall survival (OS), cumulative incidence of relapse (CIR) and non-relapse mortality (NRM) in first complete response in younger (<60 years) AML patients